Somatic PTEN mutations are rare (around 5%) in sporadic breast carcinoma; however, the frequency of PTEN gene loss is approximately 30%–40%, and accounts for approximately 20%–25% of HER2-positive breast cancers [94,95]. The gene discussed is ERBB2; the disease is breast cancer.